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Abstract 
 
 c-Maf, which is one of the large Maf transcription factors, can bind to Maf 
recognition element (MARE) and activates transcription of target genes. Although 
c-Maf is expressed in macrophages and directly regulates the expression of 
interleukin-10, detailed information regarding its function in the null mutant 
phenotype of tissue macrophages remain unknown. In this study, we demonstrated 
that c-Maf is specifically expressed in the F4/80 positive fetal liver and adult 
macrophages. The expression of F4/80, which is a tissue macrophage-specific 
seven trans-membrane receptor, was dramatically suppressed in the c-Maf-deficient 
macrophage, whereas the expression of Mac-1 was not affected, suggesting that 
c-Maf is not necessary for the lineage commitment of macrophages. Luciferase 
reporter and electrophoretic mobility shift assay showed that c-Maf directly 
regulates the expression of F4/80 by interacting with the half-MARE site of the 
F4/80 promoter. These results suggest that c-Maf is required for the F4/80 
expression in macrophages in vivo. 
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Introduction 
 
 The c-Maf is a large Maf transcription factor and a cellular homolog of 
v-Maf that was isolated from a musculoaponeurotic fibrosarcoma of chicken and 
identified as the trans-forming gene of the avian retrovirus AS42 [1]. The large Maf 
proteins, Mafa, Mafb, c-Maf and Nrl, contain an acidic domain that promotes 
transcriptional activation, and a basic region and an amphipathic helix (bZip) 
domain that mediate DNA binding to Maf recognition elements (MAREs) [2-4] and 
dimer formation, respectively. Each large Maf protein has been shown to play key 
roles in cellular differentiation [1, 5-11].  
 c-Maf is expressed in lens fiber cells [9], central nervous system [12], 
chondrocytes [12, 13], T helper cells [14], and macrophages [15, 16]. 
c-Maf-deficient mice (c-Maf -/-) exhibited abnormal lens development [9], impaired 
expression of IL-4 and IL-21 in the T helper cells [14, 17] and suppressed 
expression of IL-10 in the LPS-stimulated macrophages [15, 16]. c-Maf directly 
interacts with Ets-1 and c-Myb, and this transcriptional complex is active in early 
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myeloid cell differentiation [18]. However, detailed characterization of the c-Maf 
function in tissue macrophages still remains unknown. 
 We previously reported that in the F4/80 promoter region there is a 
highly-conserved half-MARE site, which is essential for the transcriptional 
activation of F4/80 gene by Mafb, other member of the large Maf transcription 
factor family [10]. F4/80 was established as one of the most specific cell-surface 
markers for the murine tissue macrophages [19, 20]. Recently, it was reported that 
F4/80 was crucial for the generation of the antigen specific regulatory T cell that is 
essential for peripheral tolerance induction [21]. 
 In the present report, we analyzed c-Maf -/- mice and demonstrated that c-Maf 
is predominantly expressed in the F4/80-positive fetal liver macrophages, and is 
essential for the F4/80 expression. However, expression of Mac-1 was not altered in 
c-Maf -/- fetal liver macrophage in comparison with that of the wild-type (WT) 
control. The results obtained from the luciferase reporter assay as well as EMSA 
showed that c-Maf bound to the MARE site of the F4/80 promoter region. These 
data suggest that c-Maf is required for the expression of F4/80 in vivo as same as 
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Mafb [10]. Regulation of F4/80 by the large Maf transcription factors might control 
the induction of antigen specific peripheral tolerance. 
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Materials and methods 
 
Animals. c-Maf -/- mice were originally generated with a 129/Sv background [9] 
and have been backcrossed to C57BL/6J for more than seven generations. 
Genotypes were determined by PCR analysis of tail DNA. The nucleotide 
sequences of the primers used for the PCR analysis are follows: c-Maf 1829s (orf) 
5’-CTGCCGCTTCAAGAGGGTGCAGC-3’, c-Maf 3’ (orf) 
5’-TCGCGTGTCACACTCACATG-3’, c-Maf geno 5’ (lacZ) 
5’-TGTTCACGTTCGAGCTTTC-3’, β-gal 3’(c-Maf -/-) 
5’-GATTAAGTTGGGTAACGCC-3’. All experiments were performed according 
to the Guide for the Care and Use of Laboratory Animals at the University of 
Tsukuba. 
 
Reconstitution of hematopoietic cells with c-Maf-deficient fetal liver cells. The 
donor cells for hematopoietic reconstitution were prepared from E14.5 fetal livers 
of WT and c-Maf -/- (C57BL/6J-Ly5.1) mice. Suspensions of single fetal liver cells 
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were prepared by mechanical disruption, grinding with a syringe insert against a 35 
µm nylon cell strainer (BD Biosciences, San Jose, CA). The donor cells were 
injected into the tail vein of 8-10 weeks old C57BL/6J-Ly5.2 mice, previously 
exposed to X-ray in doses of 1000R. The reconstitution efficiency was checked by 
FACS by monitoring the Ly5.2/5.1 ratio of peripheral blood cells. Mice showing 
more than 90% reconstitution were used for analysis. 
 
Immunohistochemical analysis. E14.5 embryos were fixed in 4% 
paraformaldehyde, and several 4 µm frozen sections were cut. Frozen sections were 
washed in PBS, and the intrinsic peroxidase activity was blocked with 3% H2O2. 
After blocking the sections for 1 hr in PBS containing 10% goat serum, 2% skim 
milk and 0.2% polyoxyethylene sorbitan monolaurate, they were incubated with the 
anti-c-Maf antibody (1:1000; Bethyl, Montgomery, TX) overnight at 4ºC. The slides 
were further incubated with EnVision+ System Labeled Polymer-HRP Anti-rabbit 
antibody (Dako Cytomation, Glostrup, Denmark) and substrate DAB (Nichirei 
Bioscience Inc., Tokyo, Japan). Next, they were treated with rat anti-F4/80 antibody 
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(1:1000; Serotec, Oxford, UK), incubated with anti-rat IgG alkaline phosphatase 
(1:300; Jackson ImmunoResearch, West Grove, PA), and then stained with using the 
BCIP/NBT substrate system (Dako Cytomation).  
 
Real time RT-PCR analysis of fetal liver macrophages. Macrophages were prepared 
from E14.5 fetal livers of WT and c-Maf -/- mice. Suspensions of single fetal liver 
cells were prepared as described above. Mac-1 positive cells were labeled with 
Mac-1+ magnetic beads to separate macrophages by MACS™ system (Milteney 
Biotech, Bergisch-Gladbach, Germany). Total RNA was extracted from the cells 
using the RNeasy Mini Kit (Qiagen, Valencia, CA). The c-Maf, Mafb and F4/80 
mRNA levels were examined by real time RT-PCR using the Thermal Cycler Dice 
Real Time System (Takara Bio, Shiga, Japan). This procedure enabled 
standardization of initial mRNA content of cells relative to the amount of Hprt 
mRNA. The following specific primers were used for PCR; F4/80-forward: 
5’-CCCAGCTTCTGCCACCTGCA-3’, F4/80-reverse: 
5’-GGAGCCATTCAAGACAAAGCC-3’, c-Maf-forward: 
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5’-CTGCCGCTTCAAGAGGGTGCAGC-3’, c-Maf-reverse: 
5’-GATCTCCTGCTTGAGGTGGTC-3’, Mafb-forward: 
5’-TGAGCATGGGGCAAGAGCTG-3’ Mafb-reverse: 
5’-CCATCCAGTACAGGTCCTCG-3’ Hprt-forward: 
5’-TTGTTGTTGGATATGCCCTTGACTA-3’, Hprt-reverse: 
5’-AGGCAGATGGCCACAGGACTA -3’ 
 
Flow cytometric analysis. The single cell suspension of fetal liver or adult bone 
marrow cells was prepared from each genotype of littermates. Flow cytometric 
analysis was performed by using PE and APC-conjugated anti-Mac-1 (Pharmingen, 
San Diego, CA), anti-F4/80 (Serotec) antibodies were used on a DB LSR (Bectorn 
Dickinson, Mountain View, CA). The data were analyzed using Flowjo software. 
 
Macrophage colony assay. E12.5 fetal liver cells were seeded into methylcellulose 
medium (Methocult Stem Cell Technologies, Vancouver, BC) with IL-3 (20 ng/ml) 
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and GM-CSF (10 ng/ml). Seven days later, macrophage colonies were enumerated 
under an inverted microscope. 
 
Plasmid construction and transient transfection assay. The pGL3Basic-based 
mouse F4/80 promoter luciferase plasmid construct was reported previously [22]. 
The -253+mut/Luc was created using the QuikChange Site-Directed Mutagenesis 
Kit (Stratagene, La Jolla, CA) and the following PCR primers; 5’ 
CACCTCTGATGGTGGCAATCTCTTCGAAAGCTGCTGGGCTCAGTC 3’ and 
5’ GACTGAGCCCAGCAGCTTTCGAAGAGATTGCCACCATCAGAGGTG 3’. 
The italicized sequences represent the mutated site. For transient transcription, the 
c-Maf expression plasmid pEFX3-FLAG-c-Maf, construction of which was 
previously described [23] was used. Reporter and effecter plasmids were 
transfected into the RAW264.7 cells, luciferase assays were performed as described 
[10].  
 
Electrophoretic mobility shift assay (EMSA). c-Maf and mock-control proteins were 
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prepared from the 293T cells that were transiently transfected with either the 
expression plasmid pEFX3-FLAG-Mafb or the mock vector pEFX3-FLAG. 
Nuclear extracts were prepared using a NucBuster Protein Extraction Kit (Novagen, 
Madison, WI). EMSA and competitive EMSA were performed according to the 
manufacturer’s protocol using a LightShift Chemiluminescent EMSA Kit (Pierce, 
Rockford, IL). The following oligonucleotides were used as probes: Consensus 
MARE, 5’-AGCTCGGAATTGCTGACTCATCATTACTC-3’ (biotin labeled or 
non-labeled), 5’-GAGTAATGATGAGTCAGCAATTCCGAGCT-3’, Wild-type 
competitor, 5’-CTCATGGTGGCAACTCAGCAGAAAGCTGCT-3’, 
5’-AGCAGCTTTCTGCTGAGTTGCCACCATGAG-3’, Mutant competitor, 
5’-CTCATGGTGGCAACGACTACTAAAGCTGCT-3’, 
5’-AGCAGCTTTAGTAGTCGTTGCCACCATGAG-3’. 
 
Statistical analysis. The results were recorded as mean ± standard error of the mean. 
Data were analyzed by t-test to determine statistically significant difference. 
 12 
Result 
 
c-Maf is specifically expressed in the fetal liver macrophages. c-Maf -/- mice were 
originally generated with a 129/Sv background, died within a few hours after birth 
[9]. Unexpectedly, c-Maf -/- mice with C57BL/6 genetic background, 
c-Maf-deficient mice showed embryonic lethality around e15.5 (data not shown). 
Therefore, to elucidate the physiological significance of c-Maf in hematopoietic 
cells, we examined fetal liver cells at stage E14.5. To identify which fetal liver cells 
express c-Maf, we performed immunohistochemical analysis of the E14.5 fetal 
liver using the anti-c-Maf and anti-F4/80 antibodies.  Interestingly, c-Maf 
immunoreactivity was specifically observed in the F4/80-positive tissue 
macrophages (Fig. 1A). To confirm this macrophage-specific c-Maf expression, we 
next purified both Mac-1-positive and -negative cells from E14.5 fetal liver using 
magnetic beads, and examined expression of the c-Maf, Mafb and F4/80 mRNAs 
using real time RT-PCR. Consistent with the immuno-histochemistry results, real 
time RT-PCR analysis also demonstrated that the c-Maf, Mafb and F4/80 mRNAs 
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were expressed more abundantly in the Mac-1-positive cells than in the 
Mac-1-negative cells (Fig. 1B). Thus, these results suggest that in addition to Mafb 
[10], c-Maf is also predominantly expressed in the F4/80-positive fetal liver 
macrophages.   
 
c-Maf is essential for F4/80 expression in fetal liver macrophages. To gain insight 
into the physiological function of c-Maf in macrophages, we next examined the 
expression of F4/80 in the E14.5 c-Maf -/- fetal liver macrophages by 
immunohistochemistry. Surprisingly, the number of F4/80 
immunoreactivity-positive cells in the c-Maf -/- fetal liver dramatically decreased as 
compared to the WT control (Fig. 2A).  Consistent with this observation, FACS 
analysis of the fetal liver cells also showed a significant reduction of F4/80-positive 
cells in the c-Maf -/- fetal liver (0.3 %; Fig. 2B.R1) than in the WT fetal liver 
(1.05 %; Figs. 2B.R1 and 2C). On the other hand, Mac-1-positive and 
F4/80-negative fractions were increased in the c-Maf -/- fetal liver cells (Figs. 2B.R2 
and 2C). Moreover, real time RT-PCR analysis showed about 3-fold reduction in 
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the expression of F4/80 mRNA in the c-Maf -/- Mac-1-positive fraction (Fig. 2D, left 
panel). We also observed a slight change in the expression level of the Mafb mRNA 
in c-Maf -/- (Fig. 2D, middle panel). However, expression of c-Maf mRNA was not 
observed in c-Maf -/- (Fig. 2D, right panel). To determine the cause for this 
reduction, we performed a colony assay using the WT and c-Maf -/- fetal liver cells 
in the presence of IL-3 and GM-CSF, and found virtually no difference between the 
number of macrophage colonies formed as a result of this treatment (Fig. 2E). 
Hence, these results also suggest that c-Maf is required for the maturation of 
macrophages or expression of F4/80 in fetal liver cells in vivo, but is not essential 
for the macrophage lineage commitment. 
 
c-Maf is also essential for F4/80 expression in adult bone marrow macrophages. 
Since c-Maf -/-mice with C57BL/6 background are embryonic lethal around e15.5, 
we could not analyze what functional role c-Maf might play in F4/80 expression in 
adult macrophage. To circumvent this problem, analysis was carried out after 
reconstitution of hematopoietic cells using the donor cells prepared from E14.5 
 15 
fetal livers of WT and c-Maf -/- mice. As shown in Figure 3, F4/80 positive cells 
significantly decreased in the bone marrow of the mouse reconstituted with c-Maf -/- 
fetal liver cells (F4/80+Mac-1-: 2.58%, F4/80+Mac-1+: 4.75%) than the mouse 
reconstituted with the WT fetal liver cells (F4/80+Mac-1-: 13.1%, F4/80+Mac-1+: 
8.25%). In contrast, the percentage of Mac-1 positive cells in WT (F4/80-Mac-1+: 
21.1%) and c-Maf -/- (F4/80-Mac-1+: 20.3%) remained virtually same. These results 
suggest that c-Maf is also indispensable for the total expression of F4/80 in adult 
mice. 
 
c-Maf directly activates F4/80 expression. We have previously reported that the 
Mafb is required for F4/80 expression in fetal liver macrophages, and that the 
F4/80 reporter was activated by exogenous Mafb expression in the macrophage cell 
line RAW264.7 [10]. We found that F4/80 promoter region contains a highly 
conserved MARE site (Fig. 4A). Therefore, we hypothesized that c-Maf could 
directly bind to the MARE site and activate F4/80 gene expression. To prove this 
hypothesis, we transfected the promoter-firefly luciferase reporter plasmid 
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construct, which contained the 253-bp F4/80 promoter region, along with the c-Maf 
expression plasmid (pEFX3-FLAG-c-Maf) into the RAW264.7 cell line. As 
expected, the F4/80 promoter reporter was activated by co-expression of c-Maf in a 
dose dependent manner (Fig 4B). However, neither the luciferase reporter plasmid 
construct that contained the 117-bp truncated, MARE-less F4/80 promoter nor the 
luciferase reporter plasmid constructs that contained mutations in the half-MARE 
site of the F4/80 promoter (253 bp mut) was activated by c-Maf (Fig. 4B). EMSA 
demonstrated that the non-labeled MARE probe competed out the binding of c-Maf 
to the biotin-labeled consensus MARE probe, whereas the mutant MARE probe did 
not (Fig. 4C). These results suggest that c-Maf could directly regulate the 
expression of F4/80 by interacting with the highly conserved half-MARE site in its 
promoter region. 
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Discussion 
 
There are several reported studies examining the function of c-Maf in 
macrophages. It was shown that c-Maf interacts with Ets-1 and c-Myb and the 
complex can induce differentiation of human myeloid cell line [18]. Cao et al found 
that c-Maf binds to the IL-10 promoter and activates its expression, and also 
demonstrated that LPS stimulated macrophages from fetal liver of c-Maf -/- fail to 
secrete IL-10 [15, 16]. These observations suggested that c-Maf might play a 
crucial role in differentiation and function of macrophages. However, detail 
contribution of c-Maf in macrophage differentiation and function still remained 
unclear. In this study, we demonstrated that the c-Maf is required for the expression 
of F4/80 in macrophages, and our results using the reporter constructs suggest that 
c-Maf directly regulates the expression of F4/80 by binding to the half-MARE of 
the F4/80 promoter. 
 The F4/80 is a seven trans-membrane receptor, which was shown as one of 
the most specific cell-surface markers for the murine macrophages [19, 20]. A 
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recent study showed that F4/80 is required for the differentiation of antigen-specific 
CD8+ Treg cells, a process that requires direct cellar interaction of CD1d+ APCs 
with NK-T cells [21]. Although the F4/80 protein seems to have a biologically 
important function, information regarding its regulation at the transcriptional stage 
are lacking. The F4/80 has been reported to be highly and constitutively expressed 
in most resident tissue macrophages, including the red pulp macrophages in the 
spleen, microglia in the brain, Kupffer’s cells in the liver and Langerhans’ cells in 
the skin [24]. On the contrary, F4/80 is expressed at lower levels in activated 
macrophages isolated from bacilli Calmette-Guerin-infected animals [25]. 
Similarly, F4/80 expression is down regulated in IFN-γ treated macrophages [26]. 
These observations suggested that the expression of F4/80 might be under flexible 
transcriptional regulatory control for appropriate immunological response. We have 
previously demonstrated that other member of the large Maf transcription factors, 
Mafb, directly regulates F4/80 expression in E14.5 fetal liver, P0 spleen and 
cultured macrophage under non-adherent culture condition. Our results showed that 
the c-Maf is expressed specifically in the F4/80 positive cells and is also required 
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for F4/80 expression (Fig. 2A and B). Furthermore, the observed reduction in F4/80 
expression in c-Maf -/- E14.5 fetal liver macrophages is more than that was 
previously observed in Mafb-/- [10]. Taken together, these results suggest that c-Maf 
might be involved in regulating F4/80 expression. Our results are in good 
agreement with this idea, as we have found a half-MARE site in the 5’-flanking 
region of the F4/80 gene. This half-MARE site is highly conserved among 
mammals (Fig. 3A). We have demonstrated in this paper that the c-Maf binds to the 
half-MARE site and activates the F4/80 promoter (Fig. 3B and C). Since we have 
also found that the Mafb could bind to this half-MARE site (data not shown), we 
suggest that the F4/80 expression in macrophages might be cooperatively regulated 
in vivo by c-Maf and Mafb through the half-MARE of the F4/80 promoter region.  
 It is noteworthy that the expression pattern of F4/80 is different between the 
c-Maf- and Mafb-deficient macrophages in vitro. In the presence of M-CSF, Mafb 
is indispensable for F4/80 expression under non-adherent culture condition, but not 
under adherent culture condition [10]. The expression of F4/80 is, however, not 
reduced in c-Maf -/- macrophages under both adherent and non-adherent culture 
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conditions (data not shown). Our results indicate that in the presence of M-CSF the 
expression of Mafb is up-regulated in the c-Maf -/- macrophages, which in turn 
could compensate for the deficiency of c-Maf. In contrast, c-Maf is not 
up-regulated in Mafb-deficient macrophages, and these macrophages show clear 
phenotype under non-adherent culture condition. Based on these results, we suggest 
that c-Maf and Mafb might be the main transcription factors for the induction of 
F4/80 expression under non-adherent culture condition, but not under adherent 
culture condition. Binding sites for the transcription factors PU.1, AP-1 and C/EBP 
were also found in the F4/80 promoter region [22]. Studies showing that PU.1 and 
AP-1 could dimerize with large Mafs [27, 28], and that C/EBP binding activity was 
affected by c-Maf [15] tend to suggest that the regulation of F4/80 expression 
might be complicated. Further analysis are needed to elucidate the detail 
mechanism. 
 In summary, we found that in addition to Mafb, the c-Maf is a key regulator 
for F4/80 expression in fetal liver and adult macrophages. It would be interesting to 
generate c-Maf and Mafb double mutant mice for an understanding of the 
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mechanisms involved in regulating the F4/80 expression and peripheral tolerance. 
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Figure legend 
 
Figure 1. c-Maf is specifically expressed in the fetal liver macrophages. (A) 
Immunohistochemical analysis of wild-type (WT) E14.5 fetal liver using the 
anti-c-Maf and anti-F4/80 antibodies. c-Maf is expressed specifically in 
F4/80-positive macrophages. Brown and Purple staining indicate the presence of  
c-Maf and F4/80, respectively. Scale bar: 40 µm. 
(B) Real time RT-PCR analysis. F4/80 and c-Maf mRNAs are expressed more 
abundantly in the Mac-1-positive cells than in the Mac-1-negative cells. Mafb is 
also predominantly detected in the Mac-1-positive cells. *: P < 0.01 
 
Figure 2. F4/80 expression is suppressed in c-Maf-deficient macrophages from 
fetal liver. (A) Immunohistochmical analysis of the WT and c-Maf -/- fetal livers 
shows reduced expression of F4/80 in c-Maf -/-. Brown staining indicates the 
presence of F4/80. Scale bars: 200 µm. (B) Single cell suspensions were prepared 
from the livers of the WT, heterozygous (c-Maf +/-) or c-Maf -/- mutant embryos at 
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stage E14.5. The cells were stained with PE-conjugated anti-F4/80 and 
APC-conjugated anti-Mac-1 antibodies, and then analyzed by flow cytometer. R1: 
F4/80-positive population of macrophages and R2: Mac-1-positive population of 
macrophages. (C) Quantification of the FACS analysis shows that the 
F4/80-positive population (gated as R1) is significantly decreased and the Mac-1 
single positive population (gated as R2) is increased in c-Maf -/-. Four embryos were 
analyzed in each genotype. (D) Real time RT-PCR analysis of Mac-1 positive 
fraction from the WT (n = 6) and c-Maf -/- (n = 4) fetal liver cells: lower levels of 
F4/80 mRNA is observed in c-Maf -/- compared with that in the WT.  (E) The 
number of macrophage colonies induced by IL-3 and GM-CSF: control WT (n = 3) 
and c-Maf -/- (n = 6). E14.5 fetal liver cells were treated with IL-3 and GM-CSF as 
described in the Materials and methods. *: P < 0.05. **: P < 0.01. n.d.: not detected. 
 
Figure 3. Flow cytometric analysis of bone marrow cells from adult mice 
reconstituted with c-Maf +/- and c-Maf -/- E14.5 fetal liver cells. (A) FACS profile of 
F4/80/Mac-1 myelomonocytic populations from bone marrow. (B) Quantification 
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of F4/80 positive cells and Mac-1 positive cells from c-Maf +/- (n = 3) and c-Maf -/- 
(n = 3). *: P < 0.05. 
   
Figure 4. Identification of c-Maf-responsive region in the F4/80 promoter.  
(A) Analysis of the 5’-flanking region of the F4/80 gene by the Ensembl Genome 
Database website identified highly conserved mammalian c-Maf binding 
(half-MARE) site (TCAGCA + AT rich) and C/EBP binding site (RTTGCGYAAY , 
where R = A or G, and Y = C or T). (B) Reporter assay. The macrophage cell line 
RAW264.7 was co-transfected with an indicated F4/80 promoter-reporter plasmid 
construct (wild-type: 253 bp, MARE-deleted: 117 bp, MARE containing mutations: 
253 bp mut) along with the c-Maf expression plasmid, and the relative luciferase 
activity was measured as described in Materials and methods. The relative 
luciferase activities of the reporter plasmids are shown on the right hand panel and 
are presented as values relative (-fold) to that of the cells transfected with the empty 
reporter vector (0 ng) and the c-Maf expression plasmid. Error bars; SEM. (C) 
c-Maf and mock-control proteins were prepared from the 293T cells transfected 
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with the c-Maf and the mock expression plasmids, respectively, and were used in 
EMSA as described in Materials and methods. Lane 1: biotin labeled MARE probe. 
Lanes 2-9: c-Maf protein, indicated biotin labeled MARE (WT or mutant) probe, 
and increasing amounts of the unlabeled competitor oligonucleotide. Lane 10: 
mock protein and biotin labeled MARE probe. 
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